Clinical Trials

Showing trials with last updates posted in 2024.

NCT04518852 | COMPLETED | PHASE2
27 participants

TACE, Sorafenib and PD-1 Monoclonal Antibody in the Treatment of HCC

Study Type:
INTERVENTIONAL
Last Updated:
2024-06-25
Start Date:
2020-09-14
Completion:
2022-07-31
Conditions
  • Hepatocellular Carcinoma
  • Liver Neoplasms
  • Digestive System Neoplasms
  • Sorafenib
  • Molecular Mechanisms of Pharmacological Action
  • Liver Diseases
  • Antineoplastic Agents
  • Protein Kinase Inhibitors
Interventions
  • COMBINATION_PRODUCT
No Results Yet
Previous
Sorted by latest updates
Next
Showing 40 trials per page